Figure 1.

In vivo anti‐staphylococcal efficacy of UA, norfloxacin (Nor) and UA–norfloxacin combination at various doses in terms of reduction of bacterial burden (Staphylococcus aureus MTCC‐96) in spleen tissue. The infection (1 × 10⁶ CFU·mL⁻¹ in 200 μL) was induced through the intravenous route. The bacterial load (CFU·g⁻¹) of spleen tissue was expressed as mean ± SEM. (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, Dunnett's test.)